NO981127D0 - Insulin-lignende vekstfaktor bindende protein3 (JGF_BP3) i behandling av P-53 relaterte tumorer - Google Patents

Insulin-lignende vekstfaktor bindende protein3 (JGF_BP3) i behandling av P-53 relaterte tumorer

Info

Publication number
NO981127D0
NO981127D0 NO981127A NO981127A NO981127D0 NO 981127 D0 NO981127 D0 NO 981127D0 NO 981127 A NO981127 A NO 981127A NO 981127 A NO981127 A NO 981127A NO 981127 D0 NO981127 D0 NO 981127D0
Authority
NO
Norway
Prior art keywords
jgf
insulin
treatment
growth factor
factor binding
Prior art date
Application number
NO981127A
Other languages
English (en)
Other versions
NO981127L (no
Inventor
Leonard Buckbinder
Nikolai A Kley
Bernd R Seizinger
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO981127D0 publication Critical patent/NO981127D0/no
Publication of NO981127L publication Critical patent/NO981127L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4743—Insulin-like growth factor binding protein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO981127A 1995-09-14 1998-03-13 Insulin-lignende vekstfaktor bindende protein3 (JGF_BP3) i behandling av P-53 relaterte tumorer NO981127L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US373095P 1995-09-14 1995-09-14
PCT/US1996/014623 WO1997009998A2 (en) 1995-09-14 1996-09-12 Insulin-like growth factor binding protein 3 (igf-bp3) in treatment of p53-related tumors

Publications (2)

Publication Number Publication Date
NO981127D0 true NO981127D0 (no) 1998-03-13
NO981127L NO981127L (no) 1998-03-13

Family

ID=21707302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981127A NO981127L (no) 1995-09-14 1998-03-13 Insulin-lignende vekstfaktor bindende protein3 (JGF_BP3) i behandling av P-53 relaterte tumorer

Country Status (8)

Country Link
US (1) US5840673A (no)
EP (1) EP0871475A2 (no)
JP (1) JP2000502322A (no)
AU (1) AU718451B2 (no)
CA (1) CA2232000A1 (no)
IL (1) IL123383A0 (no)
NO (1) NO981127L (no)
WO (1) WO1997009998A2 (no)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020135A (en) * 1998-03-27 2000-02-01 Affymetrix, Inc. P53-regulated genes
CA2370003C (en) 1999-01-13 2008-08-19 Tracey Brown A composition and method for the enhancement of the efficacy of drugs
WO2000050067A1 (en) * 1999-02-26 2000-08-31 Saltech I Göteborg Ab Method and composition for the regulation of hepatic and extrahepatic production of insulin-like growth factor-1
AU2001264769A1 (en) * 2000-05-17 2001-11-26 Oregon Health And Sciences University Induction of apoptosis and cell growth inhibition by protein 4.33
AUPQ879500A0 (en) * 2000-07-14 2000-08-10 Meditech Research Limited Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease
US9066919B2 (en) * 2000-07-14 2015-06-30 Alchemia Oncology Pty Limited Hyaluronan as a chemo-sensitizer in the treatment of cancer
US20030035788A1 (en) * 2000-09-19 2003-02-20 Desmond Mascarenhas Method for use of IGF-binding protein for selective sensitization of target cells in vivo
CA2458856C (en) * 2001-08-27 2011-02-15 Meditech Research Limited Improved therapeutic protocols
US6914049B2 (en) 2001-09-18 2005-07-05 Bioexpertise, Llc IGF-binding protein-derived peptide or small molecule
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide
EP1435986B1 (en) * 2001-09-18 2008-01-02 Bioexpertise, Llc Igf-binding protein-derived peptide
US7166288B2 (en) * 2002-02-13 2007-01-23 The Trustees Of Columbia University In The City Of New York Use of insulin-like growth factor binding protein 3 (IGF-BP3) for inhibition of tumor growth
US20040005294A1 (en) * 2002-02-25 2004-01-08 Ho-Young Lee IGFBP-3 in the diagnosis and treatment of cancer
WO2004111262A1 (en) * 2003-06-18 2004-12-23 Pharmacia & Upjohn Company Llc Method of identifying a selective chemotherapeutic agent
WO2005033132A2 (en) * 2003-10-03 2005-04-14 Genentech, Inc. Igf binding proteins
WO2006017824A2 (en) * 2004-08-06 2006-02-16 The Trustees Of Columbia University In The City Of New York Igf-bp3-related methods for inhibiting tumor growth
US7699677B2 (en) * 2004-12-28 2010-04-20 Independent Administrative Institution, Japan Agency For Marine-Earth Science And Technology Profiling float and usage of the profiling float
CA2616607C (en) * 2005-07-27 2015-06-02 Alchemia Oncology Pty Limited Therapeutic protocols using hyaluronan
JP5627181B2 (ja) * 2005-09-07 2014-11-19 アルケミア オンコロジー ピーティーワイ リミテッド ヒアルロナンおよび治療用抗体を含む治療用組成物ならびに治療方法
US20100316639A1 (en) 2009-06-16 2010-12-16 Genentech, Inc. Biomarkers for igf-1r inhibitor therapy

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004030A1 (en) * 1992-08-26 1994-03-03 Celtrix Pharmaceuticals, Inc. Method for systemic treatment of catabolic conditions and systemic tissue injury
US5573925A (en) * 1994-11-28 1996-11-12 The Wistar Institute Of Anatomy And Biology P53 proteins with altered tetramerization domains

Also Published As

Publication number Publication date
AU6975296A (en) 1997-04-01
EP0871475A2 (en) 1998-10-21
MX9801704A (es) 1998-05-31
US5840673A (en) 1998-11-24
CA2232000A1 (en) 1997-03-20
JP2000502322A (ja) 2000-02-29
IL123383A0 (en) 1998-09-24
NO981127L (no) 1998-03-13
WO1997009998A3 (en) 1997-04-10
WO1997009998A2 (en) 1997-03-20
AU718451B2 (en) 2000-04-13

Similar Documents

Publication Publication Date Title
NO981127D0 (no) Insulin-lignende vekstfaktor bindende protein3 (JGF_BP3) i behandling av P-53 relaterte tumorer
AU3622997A (en) Fabric treatment composition
AU4861493A (en) Clear leave-on treatment composition and method
AU2065397A (en) Characterized brca1 and brca2 proteins and screening and therapeutic methods based on characterized brca1 and brca2 proteins
AU2459697A (en) Anaerobic treatment process
AU7516194A (en) Wound treatment
NO952573D0 (no) Blandinger for behandling av diabetiske komplikasjoner
AU2189497A (en) Radiotherapy treatment using medial access transformation
AU6525296A (en) Wound treatment composition
ZA955010B (en) Enhanced crosslinking of natural tissues
AUPM761094A0 (en) Treatment of hides
AU1251197A (en) Treatment of liquors
AU3040795A (en) Method and composition for treating intestinal wounds or ulcers
AU2821295A (en) Compositions and methods for the treatment of tumors
DE69729004D1 (de) Photodynamische therapie zur behandlung von osteosrthritis
AU2327397A (en) Flash spinning process and flash spinning solution
AU3750395A (en) Wound treatment composition
AU1888692A (en) Composition and method for treating tumors
AU5594398A (en) Methods and compositions for preventing and treating bone loss
AU3127795A (en) Composition and treatment for baldness
AU2068295A (en) Skin treatment composition
AU5791698A (en) Methods and compositions for preventing and treating bone loss
AU2450597A (en) Methods of treating venomous bites and stings
GB9415901D0 (en) Novel compounds and treatment
ATA18093A (de) Katheter zur hyperthermie-behandlung

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application